The manuscript should be typed, double-spaced on standard-sized-paper (8.5" x 11") with 1" margins on all sides. Times New Roman font 12 pt should be used. The fonts used in the text as well as graphics should be restricted to Times New Roman, Symbol and Zapf Dingbats.
The title page should contain a clear, concise and informative title of the article followed by the names and affiliations of the authors. The affiliation should comprise the department, institution, city, and state (or nation) and should be typed as a footnote to the author's name. The Corresponding Author must indicate his or her complete mailing address, office/cellular phone number, fax number, and email address at the lower left of the Title Page.
The abstract should not more than 200 words and should provide a brief details about objectives of study, materials and methods, Results and Conclusions. Abstract should not be structured, it should be a single paragraph without subheadings. Abstract must be followed by four-six keywords.
This should be brief and indicates aim of the study and the essential back ground information. Introduction should clearly state the hypothesis or purpose statement, how and why the purpose or hypothesis was developed and why the author deems it important.
Material and methods
Please provide concise but complete information about the material and the analytical, statistical and experimental procedures used. This part should be as clear as possible to enable other scientists to repeat the research presented. The use of subheadings to divide the text is encouraged. Primary headings should be in BOLD CAPITAL LETTERS. Secondary or subheadings should be in Bold sentence case. Third level subheadings should be in Italicized sentence Case. In case of animal/human experiments or clinical trials authors must give the details of ethical approval.
Result and Discussion
Data acquired from the research with appropriate statistical analysis described in the methods section should be included in this section. In this part, the same data/ information given in a table must not be repeated in a figure, or vice versa. Tables and Figures should be self explanatory and it is not acceptable to repeat extensively the numerals from tables into text and give lengthy and unnecessary explanations of the Tables and Figures. Discussion should relate the results to current understanding of the scientific problems being investigated in the field.
This should clearly explain the main conclusions of the work highlighting its importance and relevance.
Reference should be cited in the text by author’s last name & year.
Single author: the author's name (without initials) and the year of publication eg. (Martin, 2009). Two authors: Last name of both the authors and year of publication should be used i.e. (Mishra and Ahmed, 2010). Three or more authors: first author's name followed by et al and year of publication i.e. (Das et al., 2012).
References should be arranged in alphabetical order and further shorted in chronological manner.
Ramesh CK, Rehman A, Prabhakar BT, Vijay Avin BR, Aditya Rao SJ. Antioxidant potential in sprouts vs. seeds of Vigna radiata and Macrotyloma uniflorum. J App Pharm Sci, 2011; 1:99-103.
Reference to a book:
Vyas SP, Khar RK. 2001. Targeted and controlled drug delivery. New Delhi, India: CBS Publisher and Distributor.
Chapter in an edited book:
Chandrasekaran SK, Benson H, Urquhart J. 1978. Methods to achieve controlled drug delivery: The biomedical engineering approach. In: Robinson JR, ed. Sustained and Controlled Release Drug Delivery Systems. New York: Marcel Dekker 557-93.
Webpage with authors
Anchal Sankhyan and Pravin Pawar. 2012. Recent Trends in Niosome as Vesicular Drug Delivery
System. [ONLINE] Available at: http://www.japsonline.com/counter.php=497. [Accessed 08 July 2012].
Webpage without authors
How to cite web reference. 2011. Available at: http://www.japsonline.com/authors-guidelines.php [Accessed 08 July 2012].
Webpage with no date:
How to cite web reference. Available at: http://www.japsonline.com/authors-guidelines.php [Accessed 08 July 2012].
AUTHORSHIP AND ACKNOWLEDGEMENTS
All the authors in a manuscript are equally responsible for the technical information communicated to the journal. Thus, it is necessary that all authors must read and approve the final version of the manuscript before submitting it to the journal. All named authors must have made an active contribution to the conception and design and/or analysis and interpretation of the data and/or the drafting of the paper and all must have critically reviewed its content and have approved the final version submitted for publication. Participation solely in the acquisition of funding or the collection of data does not justify authorship.
JAPS follows the definition of authorship given by International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
- Drafting the work or revising it critically for important intellectual content; AND
- Final approval of the version to be published; AND
- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Authors should meet all the four conditions. As per the requirements of this journal all the manuscripts should contains Authors’ Contributions statement immediately before Acknowledgments section.
All acknowledgments should be included at the very end of the paper before the references and may include supporting grants, presentations, and so forth. Contributors who do not qualify as authors should be mentioned under Acknowledgements.
Conflict of interests
All the authors of must disclose the possible conflicts of interest/Competing Interests they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript. The Conflict of Interest statement should list each author separately by name.
The authors must declare all sources of funding received for the research submitted to the journal. Authors should give the name of granting agencies and grant numbers, along with a short description of each funder’s role. Only the funding related to the submitted work should be mentioned and authors are NOT required to provide the complete list of every single grant that supports them.
TABLES & FIGURES
Tables and figures should not be embedded in the text, but should be included at the end of the manuscript on separate pages. Tables should be created with a word processor and cited consecutively in the text. To ensure the highest print quality, your figures must be submitted in TIF/JPG/JPEG format with minimum 300 dpi or higher resolutions. Captions/legends will be placed below figures and adjusted to 10 font size.
Patients have a right to privacy thus; all the studies should be conducted with informed consent. No identifying information, should be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. When informed consent has been obtained, it should be indicated in the article. Investigations with human subjects must follow the ethical standards formulated in the Helsinki Declaration of 1964, revised in 2000. All the experiment should be approved by the institutional human experimentation committee or equivalent.
Animal experiments must follow the ethical standards for the care and use of laboratory animals. Article involved the animal experiments must seek approval from the appropriate Ethical Committee in accordance with "Principles of Laboratory Animal Care" (NIH publication no. 85-23, revised 1985).
Clinical trial registry
We advise the authors to register the clinical trials with a clinical trial registry that allows free online access to public. Registration in the following trial registers is acceptable:
http://www.trialregister.nl/ and http://www.umin.ac.jp/ctr.
Standard abbreviations should be used throughout the manuscript. All nonstandard abbreviations should be kept to a minimum and must be defined in the text following their first use.
Article Processing Charges (APCs)
Authors are required to pay Rs. 4200/- INR (Indian Authors) or USD 150 (foreign authors) for APCs upon acceptance of manuscript. APCs are applicable only to the accepted articles.
Note: These charges are calculated for a standard length article with 20 pages in MS-Word (1 inch margin each side and two line space). Additional page charges 200 INR per page (Indian authors) or 6 USD per page (foreign authors) will be applicable for the articles beyond this limit.
Acceptance rate: 15.32 %, Review Time-Frame: 62 Days
(This data is based on the journal statistics provided by ejmanager system).